TD Cowen Reiterates Buy Rating on Vera Therapeutics (VERA)

September 15, 2026 10:46 AM

TD Cowen analyst Ritu Baral reiterated a Buy rating and $78.00 price target on Vera Therapeutics (NASDAQ: VERA).They analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found